BioSpace News Archive

Business

ATEC to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

Alphatec Holdings, Inc., a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced that it will report fourth quarter and full year 2021 financial results on March 1, 2022, after the market close.

February 7, 2022
·
1 min read
Pharm Country

Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference

Johnson & Johnson will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th.

February 7, 2022
·
1 min read
Biotech Beach

Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics

Bridge Biotherapeutics (KQ288330), today announced a research collaboration to discover and characterize novel reactive groups that target non-cysteine residues to uncover new druggable sites in targets of high therapeutic value.

February 7, 2022
·
3 min read
Drug Development

Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Patients With Fabry Disease

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced updated preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

February 7, 2022
·
8 min read
BioMidwest

Sera Prognostics To Present At Upcoming February 2022 Investor Conferences

Sera Prognostics Inc. announced that the company will present at the upcoming virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference and the virtual Citi 2022 Healthcare Conference: Services, MedTech, Life Science Tools & HCIT.

February 7, 2022
·
5 min read
Bio NC

Seqirus, a Business of CSL Limited, Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology

Seqirus, a global leader in influenza prevention and a business of CSL Limited, announced an investment in a new Research and Development facility located in Waltham, Mass.

February 7, 2022
·
9 min read
Biotech Beach

Revelation Biosciences Inc. to Present at 2022 BIO CEO & Investor Conference

Revelation Biosciences Inc. announced that its Chief Executive Officer James Rolke will present a corporate overview in-person at 10:45 a.m. EST on February 14, 2022 at the BIO CEO & Investor Conference, which is being held at the New York Marriott Marquis in New York City, NY on February 14-17.

February 7, 2022
·
1 min read
NanoPass’s intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology

Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination.

February 7, 2022
·
3 min read
Business

Bijoyesh Mookerjee, M.D. named Chief Medical Officer, Oncology for Simcere Pharmaceuticals

Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group.

February 7, 2022
·
2 min read